bioRxivBiochemistryPreprint
Graded and cross-reactive JAK-receptor interactions broaden the one-receptor, one-JAK rule
Mukesh Kumar Venkat RamaniiD, Juan L. MendozaiD, Kailin Guo, Yannik Leuz, Jillian Bonilla, Haley A. HardtkeiD
Abstract
Cytokine receptors signal through a dedicated Janus kinase (JAK) that is thought to be constitutively bound to the receptor intracellular domain (ICD). We tested this one-receptor, one-JAK model biophysically. A bead-based screen of JAK1 and TYK2 against 32 receptor ICDs, confirmed by microscale thermophoresis to measure affinity, revealed dissociation constants spanning tens of nanomolar to tens of micromolar, indicating that many interactions are not high-affinity and may not be constitutive. Binding was also widely cross-reactive: GMCSFR bound both JAK1 and TYK2, and IL2R{beta} bound TYK2 far more tightly than JAK1. In cells, GM-CSF signaled through JAK1 when JAK2, JAK3, and TYK2 were inhibited. JAK-receptor pairing is therefore permissive and graded rather than exclusive and constitutive.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Specificity and promiscuity of JAK recruitment regulates pleiotropy of cytokine-receptor signaling
E. Zoler, T. Meyer, … G. Schreiber·bioRxiv·Oct 4, 2023
- Differential functional coupling in Gp130-JAK complexes expands the plasticity of the interleukin-6 signaling axis
A. McFarlane, J. Sotolongo Bellon, … I. Moraga·bioRxiv·May 24, 2023
- STAM Interaction with Hrs Controls JAK/STAT Activation by Interferon-α at the Early Endosome
N. Zanin, C. M. Blouin, … C. Lamaze·bioRxiv·Jan 2, 2019
- Tuning of cytokine signaling through imbalanced abundances of receptors and kinases
Léa Sta, Guillaume Voisinne, … Grégoire Y Altan-Bonnet·bioRxiv·Oct 7, 2022
- Structural modeling of cytokine-receptor-JAK2 signaling complexes using AlphaFold Multimer
I. D. Pogozheva, S. Cherepanov, … A. Lomize·bioRxiv·Jun 14, 2023
- Selective inhibitors of JAK1 targeting a subtype-restricted allosteric cysteine
M. E. Kavanagh, B. D. Horning, … B. F. Cravatt·bioRxiv·Jan 31, 2022